上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1197Please respect copyright.PENANAwFA0dH86k2
1197Please respect copyright.PENANAsChCkGihAy
上集:https://www.penana.com/article/4711251197Please respect copyright.PENANATPeyReIeal
1197Please respect copyright.PENANAfh6W4C6Bwc
1197Please respect copyright.PENANAQJY97JCEYw
1197Please respect copyright.PENANAAbDNCvEXjc
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1197Please respect copyright.PENANAnVQjvLIYR0
1197Please respect copyright.PENANAhnkFjluB12
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1197Please respect copyright.PENANAjBIRbl9Dp3
1197Please respect copyright.PENANAjPc2NGQZKo
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1197Please respect copyright.PENANAtiTmjDdqBJ
1197Please respect copyright.PENANAAZgI57M5ha
1197Please respect copyright.PENANAEnFl4bLVsX
1197Please respect copyright.PENANASPAusSbcfg
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1197Please respect copyright.PENANABKZPnjvI1R
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1197Please respect copyright.PENANA9i48JZd54K
1197Please respect copyright.PENANACpowQibC2j
忘記甚麼是Neoantigen的話,可重溫上一集。1197Please respect copyright.PENANAeECIMt5W8b
1197Please respect copyright.PENANAB92mSK9O06
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1197Please respect copyright.PENANAVuOjnfR6BZ
1197Please respect copyright.PENANAsshUqXE2vy
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1197Please respect copyright.PENANAx7NZQL0m58
1197Please respect copyright.PENANAMRnZMOCz5T
1197Please respect copyright.PENANA12ZRqLoilE
1197Please respect copyright.PENANAV4Bp4I7p61
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1197Please respect copyright.PENANAZ2HsBBZbQz
1197Please respect copyright.PENANAYULw6gIwlU
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1197Please respect copyright.PENANAasRpULJIi7
1197Please respect copyright.PENANAXWpNq3ekMk
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1197Please respect copyright.PENANAIm0Z4ixgnq
1197Please respect copyright.PENANABygEppGX8A
1197Please respect copyright.PENANA8yFinEazgV
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1197Please respect copyright.PENANAqDGTQN9ndQ
1197Please respect copyright.PENANAE3qraKaGDo
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1197Please respect copyright.PENANAR2OiFIatWU
1197Please respect copyright.PENANAxve86nhOpu
1197Please respect copyright.PENANAz1wrENbPD7
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1197Please respect copyright.PENANAovM8lET4AW
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1197Please respect copyright.PENANA3B26pnrJZ0
1197Please respect copyright.PENANAIwrDVmBFsf
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1197Please respect copyright.PENANAp6QaT2eRu8
1197Please respect copyright.PENANA7xis1zLdPi
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1197Please respect copyright.PENANA1yScd3G6Kk
1197Please respect copyright.PENANAGoVmdtCYct
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1197Please respect copyright.PENANAnSRAbRxeQo
1197Please respect copyright.PENANADkcnRvRoB5
1197Please respect copyright.PENANAvtWBMxzduW
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1197Please respect copyright.PENANAoSyfqIH0mu
1197Please respect copyright.PENANAQrL84FCp11
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1197Please respect copyright.PENANA2fKQpKf17E
1197Please respect copyright.PENANAUglG80Nw0o
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1197Please respect copyright.PENANAhkyhoG62V3
1197Please respect copyright.PENANAKXIZg3ewX2
Link:1197Please respect copyright.PENANAhLtvBCUYp8
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1197Please respect copyright.PENANAfcbcPUafqt
1197Please respect copyright.PENANAw5nFLUD1pO
1197Please respect copyright.PENANAXtbCWwBJse
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1197Please respect copyright.PENANAAcWQaFUsbb